41

Obstructivejaundice 130530070611-phpapp01 (1)

Embed Size (px)

Citation preview

Page 1: Obstructivejaundice 130530070611-phpapp01 (1)
Page 2: Obstructivejaundice 130530070611-phpapp01 (1)

OBSTRUCTIVE JAUNDICE

Dr Fazal Hussain Khalil

Post Graduate Trainee

SBW KTH

Page 3: Obstructivejaundice 130530070611-phpapp01 (1)

OBJECTIVES

• clinical presentation of surgical Jaundice

• Review the Causes of Jaundice

• Pathophysiology of obstructive jaundice

• Important Investigations

• Management

Page 4: Obstructivejaundice 130530070611-phpapp01 (1)

Case Scenario

• 82 yr old male patient presents with progressive jaundice, itching, loss of weight .

Page 5: Obstructivejaundice 130530070611-phpapp01 (1)

History of presenting illness

• Gradually progressive jaundice

• Recurrent episodes of itching

• White stools for last 2 months

• Dark yellow urine

• Generalized weakness & fatigability- 6 months

• Weight loss in last 1 year

• Reduced appetite

• No fever

Page 6: Obstructivejaundice 130530070611-phpapp01 (1)

H/o past illness• No h/o DM, HT, TB, Chest pain

• No previous surgery(no history of cholelethiasis)

Personal History• Decreased appetite with pale stools

• Normal bladder habits but deep yellowish

• Smoker – 25 yrs

• Non-alcoholic

Page 7: Obstructivejaundice 130530070611-phpapp01 (1)

ExaminationGeneral Physical Examination:

– Pulse 88/min,BP 110/70

– anemia +, Jaundice ++

– No Lymphadenopathy

– Scratch marks

Per abdomen– Soft non-tender

– Gall bladder palpable

– No free fluid

Page 8: Obstructivejaundice 130530070611-phpapp01 (1)

Routine Investigations

• Hgb: 11.7

• Hct: 35

• WBC: 6000;

• normal differential count

• Platelet: 350,000

• Serum Crea: 1.2 mg

• Total bil: 20 mg; B1(unconj): 2 mg

B2 (conj): 18 mg

• Alkaline phosphatase: 990 U/L

• CA 19-9: 350 units/ml

• Total protein: 6.5 grams;

• USG-Abd: solid mass in distal CBD, dilated CBD, Intrahepatic Biliarydistension and distended GB

Page 9: Obstructivejaundice 130530070611-phpapp01 (1)

• Ct abdomenCt abdomen show grossly dilated

intra and extrahepatic biliary channels

With distended gall bladder

And possibilty of periampullary mass

ADVISE ERCP

Page 10: Obstructivejaundice 130530070611-phpapp01 (1)

Causes of obstructive jaundice

Page 11: Obstructivejaundice 130530070611-phpapp01 (1)

Causes of Obstructive Jaundice

Obstructive jaundice is caused by conditions that block the normal flow of bile from the liver into the intestines including:

• Cholelithiasis (gallstones)• Cholangiocarcinoma• Carcinoma pancreas• Biliary stricture (mainly iatrogenic)• Cholangitis (inflammation of the common bile duct)• Congenital structural defects• Choledochal cysts(Cysts of the bile duct)• Lymph node enlargement• Pancreatitis• Parasitic infection• Trauma, including surgical complications

Page 12: Obstructivejaundice 130530070611-phpapp01 (1)

Most common cause of obstructive jaundice in our set up

Page 13: Obstructivejaundice 130530070611-phpapp01 (1)

Clinical classification Of Obstructive Jaundice

(Benjamin Classification)

Page 14: Obstructivejaundice 130530070611-phpapp01 (1)

Type I : Complete obstructionClassical symptoms with biochemical changes

Tumors : Ca. head of Pancreas

Ligation of the CBD

Cholangio carcinoma

Parenchymal Liver diseases

Page 15: Obstructivejaundice 130530070611-phpapp01 (1)

Type II : Intermittent obstruction• Symptoms and typical biochemical changes

• But jaundice may or may not be present

Choledocholithiasis

Periampullary tumor

Duodenal diverticula

Choledochal Cyst

Papillomas of the bile duct

Intra biliary parasites

Hemobilia

Page 16: Obstructivejaundice 130530070611-phpapp01 (1)

TYPE III : Chronic incomplete obstructionWith or without classical symptoms but pathological

changes are present in bile duct and liver

Strictures of the CBD Congenital

Traumatic

Sclerosing cholangitis

Post radiotherapy

Stenosed biliary enteric anastamosis

Cystic fibrosis

Chronic pancreatitis ERCP showing distal common bile duct stricture

Stenosis of the Sphincter of Oddi

Page 17: Obstructivejaundice 130530070611-phpapp01 (1)

TYPE IV : Segmental Obstructionone or more segment of intrahepatic biliary tract is obstructed

Traumatic

Sclerosing cholangitis

Intra hepatic stones

Cholangio carcinoma

Page 18: Obstructivejaundice 130530070611-phpapp01 (1)

Pathophysiology of obstructive jaundice

Page 19: Obstructivejaundice 130530070611-phpapp01 (1)

PATHOPHYSIOLOGY OF OBSTRUCTIVE JAUNDICE

Obstructive jaundice is a condition in which there is blockage of the flow of bile out of the liver. This results in an overflow of bile and its by-products into the blood, and bile excretion from the body is incomplete

Hepatic functionsProtein synthesis,Reticulo-endothelial function Hepatic metabolism

Coagulation defect..increased prothrombin time(Decreased absroption of fat solube vitamins A,D,E,K(decreased factor XI ,XII ,platelets)

Renal functionsRenal vasoconstrictionActivation of complement system causing peritubular and glomerular fibrin deposition leading totubular and cortical necrosis

Cardiovascular effectsDecreased peripheral vascular resistanceBradycardia due to direct effect of bile salts on SA nodeDecreased cardiac contractability

Delayed wound healing due to defective synthesis of collagen

Page 20: Obstructivejaundice 130530070611-phpapp01 (1)

Investigations

Page 21: Obstructivejaundice 130530070611-phpapp01 (1)

ROUTINE

• Haemoglobin usually decreased in case of malignancy

• Rfts are usually derranged

Page 22: Obstructivejaundice 130530070611-phpapp01 (1)

BIOCHEMICAL PROFILE

1.Conjugated bilirubin> increased

2.Urine bilirubin +

3.Urobilinogen will be absent

4.S.ALK PHOSPH RAISED (most sensitive, levels are elevated in nearly 100 % of patients with extra

hepatic obstruction except in some cases of intermittent obstruction.Values usually greater than 3 times

the upper limit of reference range, and in most typical cases, they exceed 5 times the upper limit)

5. GAMMA –GLUTAMYL TRANSPEPTIDASE(GGT) is a sensitive marker of biliary tract disease is raised

6.5’nucleotidase is raised and its more specific

7.ALT AST may rise

8.Albumin decreased

9.PT prolonged clotting factor decreased

10.RFTs are usually impaired

Page 23: Obstructivejaundice 130530070611-phpapp01 (1)

Radiology

• IMAGING GOALS

To confirm the presence of an extrahepatic obstruction

To determine the level of the obstruction, to identify the specific

cause of the obstruction

To provide complementary information relating to the underlying

diagnosis (eg., Staging information in cases of malignancy).

What is the best therapeutic approach

Page 24: Obstructivejaundice 130530070611-phpapp01 (1)

Ultrasound abdomen

– More sensitive than CT for gallbladder stones and other pathology of gall bladder

– Sensitive for dilated ducts (Dilation of the extrahepatic (>10 mm) or intrahepatic(>4 mm) bile ducts suggests biliaryobstruction.)

– Liver parenchymal mass and mets

– Portable, cheap, no radiation,

– But it is operator dependant

Page 25: Obstructivejaundice 130530070611-phpapp01 (1)
Page 26: Obstructivejaundice 130530070611-phpapp01 (1)

ENDOSCOPIC ULTRASOUND (EUS)

• EUS has been reported to have up to a 98% diagnostic accuracy in patients with obstructive jaundice

• it allows diagnostic tissue sampling via EUS

guided fine-needle aspiration (EUS-FNA)• The sensitivity of EUS for the identification of

focal mass lesions in pancreas has been reported to be superior to that of CT scanning, both traditional and spiral, particularly for tumors smaller than 3 cm in diameter.

• Compared to MRCP for the diagnosis of biliarystricture, EUS has been reported to be more specific (100% vs 76%)

Page 27: Obstructivejaundice 130530070611-phpapp01 (1)

Ct scan

• Main role in malignant conditions mainly for localization of primary tumors and mets

• Best for Pancreatic Carcinoma(Highly sensitive for lesion >1mm)

•Mainly done when ultrasound fail or when there is ductal dilation on ultrasound

•also to find level and cause of obstruction

•and in malignant conditions

Page 28: Obstructivejaundice 130530070611-phpapp01 (1)

MAGNETIC RESONANCE

CHOLANGIOPANCREATOGRAPHY (MRCP)

• Noninvasive test to visualize the hepato biliarytree

• Entire biliary tree and pancreatic duct can be seen

• Best for Intra Hepatic stones and CHOLEDOCHAL CYST

• SINGLE BEST FOR CHOLANGIOCARCINOMA

• MRCP is better to determine the extent and type of tumor as compared to ERCP

Page 29: Obstructivejaundice 130530070611-phpapp01 (1)

Endoscopic retrograde cholangiogram(ERCP

• Its an invasive procedure and has therapeutic potential.

• Allows biopsy or brush cytology

• Stone extraction or stenting

COMPLICATIONS Pancreatitis

Cholangitis

Hemorrhage

Sepsis

CONTRAINDICATIONS Unfav anatomy

Pseudocyst

Rec a/c pancreatitis

Page 30: Obstructivejaundice 130530070611-phpapp01 (1)

Percutaneous TranshepaticCholangiogram (PTC)

• PTC is indicated when percutaneous intervention is needed and ERCP either is inappropriate or has failed.

• Can be used to drain biliaryobstructions.

Page 31: Obstructivejaundice 130530070611-phpapp01 (1)

Other investigations

• Oral Cholecystography (OCG)>>> useful when patient has symptoms of cholelithiasis,

but a negative ultrasound.

• also is useful for counting the number of stones present.

• HIDA SCAN- useful in a/c cholecystitis,

• DIAGNOSTIC LAPAROSCOPY-

• ANGIOGRAPHY- abnormal vasc.anatomy

• Tumor markers- CA19-9 , CEA

Page 32: Obstructivejaundice 130530070611-phpapp01 (1)

Management of Obstructive Jaundice

Page 33: Obstructivejaundice 130530070611-phpapp01 (1)

Management

Perioperative management of obstructive jaundice

• Preoperative biliary decompression improves postoperative morbidity (usually cause increased hemorrhage & infections and is mainly Indicated in severe jaundice or when there are signs of impending liver failure.Endoscopic internal drainage preferred over per-cutaneous external drainage

• Intravenous admistration of 5% dextrose saline followed by 10%mannitol or loop diuretics to prevent renal failure(12 to 24 hours prior to surgery)

• catheterization to monitor output

• Broad spectrum antibiotic prophylaxis

• Parenteral vitamin K +/- fresh frozen plasma

• Need careful post operative fluid balance to correct dehydration

• Correction of hypokalemia

• Cholestyramine and antihistamine for symptomatic relief of pruritis

Page 34: Obstructivejaundice 130530070611-phpapp01 (1)

Treatment of Obstructive Jaundice is based on the cause

1) Cholelithiasis (gallstones)

Ideally ERCP follwed by laproscopicCholecystectomy

Or open cholecystectomy with

CBD exploaration

Page 35: Obstructivejaundice 130530070611-phpapp01 (1)

2) Ca Head of Pancreas / Periampullary Carcinoma/malignancy

of lower 3rd of CBD

a) Whipple resection (pancreaticoduodenectomy) is mainly done which involves removal of

head & neck of pancreas, duodenum, distal 40% of stomach, lower CBD, GB, upper 10 cm of jejunum, regional L.Ns

and reconstruction through gastrojejunostomy,choledochojejunostmy and pancreaticojejunostomy

b) If not operable then we go for Endoscopic sphincterotomy + stenting with Percutaneous transhepatic biliary drainage

Page 36: Obstructivejaundice 130530070611-phpapp01 (1)

3) Ca gall bladder

a) if involving cbd then whipple resection is done

b) And in case of inoperable cases Endoscopic / Radiological stenting is done

4) Choledochal cyst Surgical excision of the cyst with Reconstruction of the

extra hepatic biliary tree

Biliary drainage is accomplished by Choledocho–jejunostomy

with a Roux – en – Y anastamosis

Long term follow up is necessary because of complications

like cholangitis , lithiasis , anastomotic stricture

Page 37: Obstructivejaundice 130530070611-phpapp01 (1)

5) Cholanchiocarcinoma

Surgery depends on the stage of tumor and may involve

• Removal of the bile ductsIf the tumor is at a very early stage (Stage 1), just the bile ducts containing the cancer are removed. The remaining ducts in the liver are then joined to the small bowel, allowing the bile to flow again.

• Partial liver resectionIf the tumor has begun to spread into the liver, the affected part of the liver is removed, along with the bile ducts.

• Whipple procedureIf the tumor is larger and has spread into nearby structures, the bile ducts, part of the stomach, part of the small bowel (duodenum), the pancreas, gall bladder and the surrounding lymph nodes are all removed

• If surgery to remove the tumour is not possible, it may be possible to relieve the blockage through stents through ERCP or PTC

Page 38: Obstructivejaundice 130530070611-phpapp01 (1)

6)Choledocholithiasis (stones in the CBD)

a)Treatment of choice is stone extraction through ERCP

b) Mechanical lithotripsy – through modified dormia basket

c)Through shock waves laser technology

d)Open exploration of common bile duct is indicated in Presence of multiple stones (more than 5) and Stones > 1 cm Multiple intra hepatic stones Distal bile duct strictures Failure of ERCP Recurrence of CBD stones

Page 39: Obstructivejaundice 130530070611-phpapp01 (1)

7)Strictures are usually treated by endoscopic stenting

which is comparable to that of surgery, with similar recurrence rates. Therefore, surgery should probably be reserved for those patients with complete ductal obstruction or for those in whom endoscopic therapy has failed. Surgery with Roux-en-Y choledochojejunostomy or hepaticojejunostomy is the standard of care with good or excellent results in 80 to 90% of patients.

8) Stenosis of the Sphincter of Oddi endoscopic or

operative sphincterotomy will yield good results

Page 40: Obstructivejaundice 130530070611-phpapp01 (1)

Prognostic factors( Pitt’s score)

Parameters• Type of

obstruction(malignant or benign)

• Age > 60 yrs

• S.Alb< 3gm/dl

• S.Bil > 10mg%

• S.Alk P > 100 IU

• S.Creatinine >1.3mg%

• TLC >10000/mm3

• Hematocrit < 30%

Factors Mortality

Upto 2 0%

3 4%

4 7%

5 44%

6 67%

8 100%

Page 41: Obstructivejaundice 130530070611-phpapp01 (1)

Thank You